Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06610019 · ClinicalTrials.gov registry record
Cardiovascular Multimodality Imaging Study
A clinical trial of Heart Failure and Sarcoidosis, sponsored by Montefiore Medical Center.
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 1
- Study location
NCT06610019 is a study of Heart Failure and Sarcoidosis that is actively recruiting participants, run by Montefiore Medical Center. The registered enrollment target is 5,000 participants, above the 2,036-participant average among 397 other Heart Failure trials with a reported enrollment target (146% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06610019, a study of Heart Failure and Sarcoidosis, is actively recruiting participants, sponsored by Montefiore Medical Center.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Determining the etiology of cardiomyopathy is of high clinical importance for optimal treatment strategy and prediction of prognosis. There is increased risk for cardiovascular disease and higher propensity for cardiovascular related mortality among Black and non-Hispanic White patients. Recently, advanced cardiac imaging has become a vital tool in diagnosis and risk stratification of cardiovascular disease. Very limited data is available on the prevalence and characteristics of different cardiovascular diseases in Hispanic and African American minority groups, therefore, studying different racial and ethnic minority groups in the Bronx population is an exceptionally valuable source to determine the prevalence of cardiomyopathies among minority groups along with study survival in this population. This study aims to determine the etiology of cardiovascular disease in a diverse patient population by utilizing various cardiovascular imaging modalities, with a focus on cardiac magnetic resonance (CMR) imaging and to develop risk stratification models by applying advanced cardiovascular imaging markers.
Conditions Studied
Study Locations (1)
New York
- Montefiore Health System - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2023-05-01 |
| Est. Completion | 2031-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06610019
The ClinicalTrials.gov registry entry for NCT06610019 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 5,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 2,036-participant average among 397 other Heart Failure trials with a reported enrollment target (146% higher). The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Heart Failure appearing as the primary indexed condition, and to 0 interventions.
NCT06610019 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06610019 about?
NCT06610019 is a clinical study titled "Cardiovascular Multimodality Imaging Study". Determining the etiology of cardiomyopathy is of high clinical importance for optimal treatment strategy and prediction of prognosis. There is increased risk for cardiovascular disease and higher propensity for cardiovascular related mortality among Black and non-Hispanic White patients. Recently, a...
What is the current status of trial NCT06610019?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2023-05-01. Estimated completion is 2031-12.
What conditions does trial NCT06610019 study?
This clinical trial studies the following conditions: Heart Failure, Sarcoidosis, Cardiomyopathies, Hypertrophic Cardiomyopathy, Cardiac Amyloidosis.
Who is sponsoring clinical trial NCT06610019?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06610019 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
RECRUITING · Phase 3
-
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
RECRUITING
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.